2)- Yusuke Iemura, Makito Miyake, Shinji Fukui, Tomomi Fujii, Sayuri Ohnishi, Shunta Hori, Yosuke Morizawa, Yasushi Nakai, Kazumasa Torimoto, Nobumichi Tanaka, Kiyohide Fujimoto. Depth of invasion to the bladder wall as a prognostic factor and its association with circulating cell-free DNA levels in patients with muscle-invasive bladder cancer.Current urology. 2023, 17 (4): 229-235
4)- Rabea Ahmed Gadelkareem, Ahmed Mahmoud Abdelraouf, Abdelfattah Ibrahim Ahmed, Ahmed Mohammed El-Taher, Hosny Mahmoud Behnsawy. Predictors of time-to-nadir serum creatinine after drainage of bilaterally obstructed kidneys due to bladder cancer.Current urology. 2023, 17 (4): 246-250
5)- Luca Di Gianfrancesco. The association between postvoid residual and response to standard therapy in male and female patients with non-muscle-invasive bladder cancer.Current urology. 2023, 17 (4): 251-256
6)- Tarun Jindal, Ankush Sarwal, Prateek Jain, Rajan Koju, Satyadip Mukherjee. A retrospective analysis of the factors associated with increased risk of readmission within 30 days after primary transurethral resection of bladder tumor.Current urology. 2023, 17 (4): 257-261
7)- Seyed Behzad Jazayeri, Hojat Dehghanbanadaki, Mahdie Hosseini, Pourya Taghipour, Michael W Bacchus, Elizabeth A Di Valerio, Elnaz Sarabchian, K C Balaji, Mark Bandyk. Can magnetic resonance imaging differentiate muscle invasion (T2) and lamina propria invasion (T1) urothelial carcinoma of the bladder? A systematic review and meta-analysis of Vesical Imaging-Reporting and Data System accuracy.Current urology. 2023, 17 (4): 262-267
8)- Mai Hori, Kazuki Maki, Yumiko Okuno, Koji Mikami, Takumi Takeuchi. A radiation-related second primary gastrointestinal stromal tumor in the bladder.Current urology. 2023, 17 (4): 268-270
9)- Maria A Bantounou, Josip Plascevic, Lewis MacDonald, Man Chun Wong, Neasa O'Connell, Helen F Galley. Enfortumab vedotin and pembrolizumab as monotherapies and combination treatment in locally advanced or metastatic urothelial carcinoma: A narrative review.Current urology. 2023, 17 (4): 271-279
10)- Daniel Da Silva Ferreira, Amit Satish Bhattu, Ahmed Adam. Miniaturizing the approach to upper tract renal calculi: Is smaller always better? A narrative review.Current urology. 2023, 17 (4): 280-285
11)- Sumesh Padayachee, Ahmed Adam, June Fabian. The impact of diabetes and hypertension on renal allograft survival- A single center study.Current urology. 2023, 17 (4): 286-291
12)- Benedikt Hoeh, Marina Kosiba, Mike Wenzel, Nicola Meister, Felix Preisser, Shahrokh F Shariat, Jan Lukas Hohenhorst, Andreas Becker, Philipp Mandel, Severine Banek, Frederik Roos, Pierre I Karakiewicz, Felix K H Chun, Luis A Kluth. Comparison of survival outcomes between laparoscopic versus open radical nephroureterectomy in upper tract urothelial cancer patients: Experiences of a tertiary care single center.Current urology. 2023, 17 (4): 292-298
13)- Alexandr M Pinkhasov, Matthew Beamer, Daniel Shulman, Rachel Yakubov, Esther Pinkhasov, Sergey Kravchick. A novel technique for unilateral dissection of the penile neurovascular bundle to prevent loss of penile sensation during treatment of Peyronie's disease-Initial results of a pilot study.Current urology. 2023, 17 (4): 299-302